Abstract
Objective: Using data from cancer registries to estimate thyroid cancer incidence and mortality in China, 2015.Methods: Data submitted from local cancer registries were checked and evaluated according to the criteria of data quality control, a total of 368 cancer registries' data were qualified for the final analysis. Data were stratified by area (urban/rural, eastern/central/western), sex and age, combined with national population data to estimate thyroid cancer incidence and mortality in China, 2015.Results: Approximately 200,700 new cases were diagnosed in 2015, accounting for 5.11% of all cancer cases. The crude incidence rate was 14.60/100,000. Age-standardized incidence rates by Chinese standard population (ASIRC) and world standard population (ASIRW) were 12.05/100,000 and 10.44/100,000, with the cumulative incidence rate (0–74 years old) of 1.00%. About 7,900 deaths of thyroid cancer were reported in 2015, accounting for 0.34% of all cancer deaths. The crude mortality rate was 0.58/100,000, age-standardized mortality rates by Chinese standard population (ASMRC) and world standard population (ASMRW) were 0.37/100,000 and 0.36/100,000. The age-standardized incidence and mortality in females were significantly higher than those in males (P < 0.001). The rates in urban areas were higher than those in rural areas (P < 0.001). The ASIRC in eastern areas was higher than that in central and western areas (P < 0.001), while the ASMRC in central areas was higher than that in eastern and western areas (P < 0.001).Conclusions: The burden of thyroid cancer was heavy in China, cancer control faces the problem of the disparity between geographic areas, and the incidence and mortality rates were varied by sex and age. Targeted cancer preventive measures should be put into practice.
Highlights
Thyroid cancer is the most common endocrine and head-andneck malignancy globally
In 2015, the estimated new cases diagnosed with thyroid cancer were 200,700 in China, accounting for 5.11% of all new cancer cases, with the incidence rate ranked 7th in all kinds of cancer
Thyroid cancer was found burdened with the high incidence, the mortality rate remained relatively low in China in 2015
Summary
Thyroid cancer is the most common endocrine and head-andneck malignancy globally. Paes et al reported in a research in 2010 that thyroid cancer incidence is rising at a rate that is the fastest of all malignancies [1]. According to the Global Cancer Observatory (GLOBOCAN) 2018 from International Agency for Research on Cancer (IARC), about 567,200 new cases were diagnosed, and 41,100 deaths were caused by thyroid cancer in 2018 [2]. The incidence rate of thyroid cancer is increasing in China. According to the annual report of China Cancer Registry 2018, thyroid cancer has become one of the 10 major cancers threatening the health of Chinese residents [3]. Some researchers have reported the incidence and mortality rates of thyroid cancer in the regional level [5,6,7], while the nationwide data is still lacked. As national cancer registration data were not publicly available in the same fashion as the Surveillance, Epidemiology, and End Results
Full Text
Topics from this Paper
Chinese Standard Population
Eastern Areas
Central Areas
World Standard Population
Burden Of Thyroid Cancer
+ Show 5 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Chinese journal of oncology
Nov 23, 2017
Chinese Journal of Cancer Research
Jan 1, 2019
Chinese Journal of Cancer Research
Jan 1, 2020
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Dec 23, 2020
Chinese journal of oncology
Dec 23, 2020
Chinese Journal of Cancer Research
Jan 1, 2016
Chinese Journal of Cancer Research
Mar 1, 2012
Chinese Journal of Cancer Research
Jan 1, 2016
Chinese Journal of Preventive Medicine
Oct 6, 2019
Chinese journal of oncology
Jan 23, 2021
Chinese journal of oncology
Nov 23, 2018
Chinese Journal of Cancer Research
Jan 1, 2019
Chinese journal of oncology
Aug 23, 2018
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Mar 23, 2023
Chinese Journal of Preventive Medicine
Aug 6, 2017
Frontiers in Oncology
Frontiers in Oncology
Nov 27, 2023
Frontiers in Oncology
Nov 27, 2023
Frontiers in Oncology
Nov 27, 2023
Frontiers in Oncology
Nov 27, 2023
Frontiers in Oncology
Nov 27, 2023
Frontiers in Oncology
Nov 27, 2023
Frontiers in Oncology
Nov 27, 2023
Frontiers in Oncology
Nov 27, 2023
Frontiers in Oncology
Nov 27, 2023
Frontiers in Oncology
Nov 24, 2023